Imipramine (HCl)
Overview
Imipramine (HCl) was recognized as an antidepressant in 1950s and is the prototype drug of tricyclic antidepressants of the class dibenzazepine class. Tricyclic antidepressant is used for almost four decades. Chemically itclosely related to the phenothiazines. itthe first of the tricyclic antidepressants to be used. Imipramine (HCl) has characteristic three ring nucleus. itprepared by chemical synthesis. italso used in the treatment of childhood enuresis, anxiety in panic syndrome, and chronic pain.
Categories
- 24 Psychotherapeutic drugs
- 24.2 Drugs used in mood disorders
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Imipramine (HCl)'s dosage details are as follows:
Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
50 to 100 mg | 75 (75) | As recommended. | | A single dose at bed time, usual maintanace. |
75 mg | 75 (75) | 24 hourly | PO | Gradually increased to 150 to 200mg |
Paedriatic Dosage (20kg)
|
25 mg | 25 (25) | As recommended. | | For children 6 to 7 years (20-25kg) |
50 | 50 (50) | As recommended. | | For children aged 8 to 11 years (25-35kg) |
1 to 2 mg/kg | 1.5 (1.5) | 24 hourly | Oral | Recommended for 5-12 Years Children at Bed Time |
Neonatal Dosage (3kg)
|
| | | | Not recommended in this age group |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Imipramine (HCl)
Back to top
Manufacturers of
Imipramine (HCl)
in Pakistan
Back to top
Previous Drug Generic - Next Drug Generic